LYKALABSNSELyka Labs Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 27 May · 12:01 IST

Lyka Labs Limited has informed the Exchange about Copy of Newspaper Publication

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.4%1-day move
₹60.40
prior close
₹57.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.6+0.5+0.7-5.4-3.1-4.0-4.2-0.1+5.3+15.0+20.8+6.3
Up moveDown movePending
AI summary

Lyka Labs Limited has published its audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2026. The Board of Directors approved these results at their meeting held on 25th May 2026. As per SEBI regulations, the results were published in Financial Express (English, all editions) and Janadesh (Gujarati, Bharuch edition) on 27th May 2026. The company has also made these results available on its website. This is a routine regulatory filing required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Likely market impact

This is a standard quarterly and annual results announcement. The filing indicates the company has completed its statutory audit and board approval process for FY2026. The actual financial numbers are contained in the attached newspaper publication. Investors should refer to the detailed results for assessing company performance.